<DOC>
	<DOC>NCT00844792</DOC>
	<brief_summary>The purpose of this study is to see if an intervention of antioxidants(vitamin E, selenium and lycopene) can change (reduce) prostate tumor size and alter certain markers that can affect tumor growth and prostate cancer aggressiveness.</brief_summary>
	<brief_title>Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<criteria>Diagnosis of a Gleason score &gt; or = to 7 adenocarcinoma of the prostate At least 30% of one core involved Radical prostatectomy planned Willingness to discontinue use of supplements at least 4 weeks prior to study intervention (for subjects using vitamin E, selenium or lycopene at time of consent) ability and willingness to consume study intervention for 6 8 weeks prior to radical prostatectomy. Previous treatment for prostate cancer Current use of finasteride or dutasteride</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Male Urogenital Diseases</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>Vitamin E</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Lycopene</keyword>
	<keyword>Selenium</keyword>
</DOC>